title: Successful combination: existing drugs boost cancer vaccine responses.
authors: Eva M
authors: EM
authors: Riedmann
mesh_terms: D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000628:therapy*; D019496:Cancer Vaccines / Q000008:administration & dosage / Q000276:immunology*; D000077561:Daclizumab; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000494:pharmacology; D000077289:Letrozole; D008175:Lung Neoplasms / Q000628:therapy*; D008562:Membrane Glycoproteins / Q000008:administration & dosage / Q000276:immunology; D051379:Mice; D009570:Nitriles / Q000008:administration & dosage / Q000494:pharmacology; D016896:Treatment Outcome; D014230:Triazoles / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D007074:Immunoglobulin G; C518273:L-BLP25; D008562:Membrane Glycoproteins; D009570:Nitriles; D014230:Triazoles; D000077289:Letrozole; D000077561:Daclizumab